Home > Drug Search >
  • company_query: Bioglan Pharma
  •   > 
Drug Filter
Category:
chemistry (17) biology (4)
Status:
Approved (3) NDA Filing (2) Phase Ⅲ (2) Phase Ⅱ (9) Phase Ⅰ (5)
Clinical Stage:
Pending (3) Active (5) Discontinued (10)
Bio-Type:
CAR T cell therapy (2) Recombinant cytokines (2)
Indication:
Anemia (1) Anxiety (1) Arrhythmia (1) Benign prostatic hypertrophy (1) Breast cancer (1) Fever (1) Hookworm infections (1) Ascaris infection (1) Glioblastoma multiforme (1) HIV infection (1) Hyperlipidemia (1) Lung cancer (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Osteosarcoma (1) Sleep disorder (1) Solid tumours (1) Head and neck cancer (1) Pain (2) Prostatitis (1) Sepsis (1) Septic shock (1) Glioblastoma (1) Esophagus cancer (1) Gastrointestinal disorders (2) Muscle spasticity (1) Infectious disease (1) hematological malignancies (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top